A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032)

Clinical trial NCT07646860 · RECRUITING

Trial details

NCT number: NCT07646860
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2026-08-31
Primary completion: 2029-05-24
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.